Purchase Order 75N92B24P00064

Award Date 3/7/24
Potential Completion Date 3/6/25
Potential Value $25K
Ultimate Awardee
Not listed
PSC Category
6810 - Chemicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Pleasanton, CA 94588, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
10X Genomics, Inc., doing business as 10X Genomics, has been awarded a firm fixed price purchase order valued at $24,999 by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to deliver a CHROMIUM NEXT GEM KIT and a 3' CELLPLEX KIT. Performance will take place in Pleasanton, California over approximately six weeks concluding in late October 2023. The products are being acquired to support research programs at the NIH aimed at advancing understanding of...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $30,539 firm fixed price purchase order to 10X Genomics, Inc. for the acquisition of Chromium Next GEM Single Cell 5' Kits and Library Construction Kits. Under the terms of the contract, 10X Genomics will provide 16 reactions of the Chromium Next GEM Single Cell 5' Kit v2 and 48 reactions of the Library Construction Kit. The place of performance is 10X...
10X Genomics, Inc., doing business as 10X Genomics, has been awarded a $25,000 firm fixed price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to deliver CHROMIUM NEXT GEM SINGLE CELL REAGENTS AND DUAL INDEX KIT (AMBIS #2202167). Performance will take place in Pleasanton, California over a period of two months concluding at the end of February 2024. No subcontractors or set aside designations were indicated. This contract supports...
This firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to 10X Genomics, Inc. The $24,999.00 contract is for the delivery of 10X CHROMIUM NEXT GEM-X AND CHROMIUM SINGLE CELL HUMAN KITS, which are used for single-cell RNA sequencing and other single-cell analysis applications. 10X Genomics is a life sciences technology company that specializes in products and services...
10X Genomics, Inc. has been awarded a firm fixed price purchase order valued at thirty-seven thousand eight hundred sixteen dollars by the Department of Health and Human Services' National Institutes of Health Clinical Center. The contract calls for the delivery of Chromium Next Gem single cell fixed RNA sample preparation kits to the agency's facility in Pleasanton, California, with an completion date of April 15, 2024. As a prime contractor, 10X Genomics specializes in single-cell and...
The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $24,894 purchase order to 10X Genomics, Inc. for CHROMIUM NEXT GEM CHIP G SINGLE CELL KITs. As the prime contractor, 10X Genomics will provide its next generation single cell analysis kits to support genomic research activities at the NIH Clinical Center in Bethesda, Maryland. The firm fixed price contract runs from July 18, 2023 through September 30, 2023 for delivery of the specified products to...
This is a firm-fixed-price delivery order awarded by the National Institute on Aging (NIA), part of the National Institutes of Health (NIH), to 10X Genomics, Inc. The $22,585.50 contract is for the provision of the Chromium Next GEM Single Cell 3' Kit V3.1 (16 reactions), which supports single-cell genomic analysis applications. This delivery order is part of a larger indefinite delivery contract valued at up to $750,000 that 10X Genomics holds with the NIH's National Institute of Neurological...
10X Genomics, Inc. has been awarded a firm fixed price purchase order valued at twenty-four thousand eight hundred thirty-five dollars ($24,835) by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases. The contract is for Chromium Kits to support genomic analysis through March 2024. As a prime contractor, 10X Genomics specializes in single-cell and spatial analysis products including kits, instruments, software and...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $24,324 firm fixed price purchase order to 10X Genomics, Inc. for Chromium Kits. 10X Genomics will deliver its genomic analysis products to support NIH research efforts through September 2024. As the prime contractor, 10X Genomics will provide its proprietary kits and associated services from its Pleasanton, California location. The award was made using an...
The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $25,000 firm fixed price purchase order to 10X Genomics, Inc. for Chromium Kits. 10X Genomics will deliver its Chromium Kits to support NIH research efforts from its Pleasanton, California location over the one year period of performance beginning in September 2023. The award utilizes 10X Genomics' products and services to advance NIH's mission to seek...

10X Genomics, Inc. is providing $24,999 worth of Chromium Next GEM Single Cell 3' Kit V3.1 products to the National Institutes of Health's National Institute of Arthritis and Musculoskeletal and Skin Diseases under a firm fixed price purchase order awarded on March 7, 2024. The place of performance is Pleasanton, California, with an expected completion date of March 6, 2025. The kit supports single cell RNA sequencing research efforts at the National Institute of Arthritis and Musculoskeletal and Skin Diseases, which seeks to better understand diseases affecting the bones, joints, and skin. No set-aside designation was used for this award to the prime contractor, 10X Genomics.

Generated 3/8/24, 10:49 AM